Replies to post #182 on Immatics NV (IMTX)

[FACT-MASTER]

News out this morning on IMA401

Not as good as i was thinking yesterday, also looks like BMS is pulling out.
https://finance.yahoo.com/news/immatics-presents-clinical-proof-concept-092500575.html

Remember this was targetting mage, IMA402 was targetting prame, so there is still hope those results are better. Hope we get an update on IMA402 before year end. TCRX has had excellent success with leukemia targetting prame.
I have to admit today's news is not that good, imo